Director/PDMR Shareholding

RNS Number : 6491J

GlaxoSmithKline PLC

01 April 2010

 



Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons

I give below details of changes in the directors' interests in the Ordinary shares and American Depository Shares (ADSs) of GlaxoSmithKline plc.

On 31 March 2010, the Company's Non-Executive Directors were provisionally allocated awards over Ordinary shares at a price of £12.67 per Ordinary share and $38.29 per ADS under the share allocation arrangements for Non-Executive Directors for the period of service from 1 January 2010 to 31 March 2010:

Non Executive Director	Ordinary Shares	American Depository Shares (ADSs)
Sir Christopher Gent	2,663.77
Prof. Sir Roy Anderson	813.93
Dr Stephanie Burns		399.73
Mr Lawrence Culp		799.46
Sir Crispin Davis	3,058.41
Sir Deryck Maughan		799.46
Mr James Murdoch	2,663.77
Dr Daniel Podolsky		839.43
Mr Tom de Swaan	1,060.58
Sir Robert Wilson	813.93

The Company and the Non-Executive Directors were informed of these allocations on 1 April 2010.

This notification relates to transactions notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a).

S M Bicknell

Company Secretary

1 April 2010

 

END

 

 

RDSLFLFBBZFEBBF